Approval · Notice of Compliance 23659 · 2020
STRESNIL: Notice of Compliance 23659
Issued May 21, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23659
- Date
- May 21, 2020
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addiition of drug manufacturing and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STRESNIL | 00755710 | Marketed |
Medicinal ingredients
- AZAPERONE 40 MG per ML